Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction ( GEJ ) adenocarcinoma in combination with fluoropyrimidine- and platinum-
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or ... Canada ...